Cargando…
Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations
Mitophagy is the selective degradation of mitochondria by autophagy. It promotes the turnover of mitochondria and prevents the accumulation of dysfunctional mitochondria, which can lead to cellular degeneration. Mitophagy is known to be altered in several pathological conditions, especially in neuro...
Autores principales: | Maestro, Ines, de la Ballina, Laura R., Porras, Gracia, Corrochano, Silvia, De Lago, Eva, Simonsen, Anne, Boya, Patricia, Martinez, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9603920/ https://www.ncbi.nlm.nih.gov/pubmed/36293534 http://dx.doi.org/10.3390/ijms232012676 |
Ejemplares similares
-
Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis
por: Martínez-González, Loreto, et al.
Publicado: (2021) -
New Statement about NRF2 in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Lastres-Becker, Isabel, et al.
Publicado: (2022) -
Upregulation of CB(2) receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis
por: Fernández-Trapero, María, et al.
Publicado: (2017) -
Amyotrophic Lateral Sclerosis: An Emerging Era of Collaborative Gene Discovery
por: Gwinn, Katrina, et al.
Publicado: (2007) -
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
por: Katzeff, Jared S., et al.
Publicado: (2022)